Thromboelastometry in Acute Hemorrhage Induced by Traumatic Injury of the Brain - a pilot study.
Not Applicable
- Conditions
- S06D68Intracranial injuryOther coagulation defects
- Registration Number
- DRKS00011559
- Lead Sponsor
- Institute for Research in Operative Medicine (IFOM)Private University Witten-Herdecke (UWH)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
1.) Clinical diagnosis of severe TBI (GCS=8)
2.) Suspicion of clinically relevant hemorrhage
3.) Clinical indication for CT scan
4.) Presentation to the hospital within 24 hours after injury
Exclusion Criteria
Severe pre-existing neurological disorder that would confound outcome asessements (according to CENTER-TBI)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The percentage of patients in whom the ROTEM® guided coagulation management algorithm has been started in regard to stepwise decision-making either in favor or against the suggested intervention, including action taken or the decision not to perform any intervention, according to EXTEM and FIBTEM A5 results within 60 minutes after admission of the patient to the hospital.
- Secondary Outcome Measures
Name Time Method 1.) Time to first ROTEM® results after admission and after blood sampling. 2.) Time from admission to administration of agents suggested by the algorithm. 3.) Time from the first ROTEM® results to administration of agents suggested by the algorithm. 4.) Adherence to the algorithm and capturing reasons for non-adherence. (N.B.: Adherence will be defined as decision-making according to the algorithm within 60 minutes after initiation of the algorithm. Exact dosing of agents administered will not be taken into account.) 5.) ROTEM® results at 60 minutes after initiation of the algorithm. 6.) Additional systemic haemostatic interventions. 7.) Clinical outcome data as captured in the CENTER-TBI CRF.